GENNEX LABORATORIES
Back to Income Statement
|
GENNEX LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹11 Cr | ₹6.19 Cr | ₹4.11 Cr | ₹4.04 Cr | ₹1.86 Cr |
What is the latest Consolidated Net Profit of GENNEX LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹11 Cr |
| Mar2024 | ₹6.19 Cr |
| Mar2023 | ₹4.11 Cr |
| Mar2022 | ₹4.04 Cr |
| Mar2021 | ₹1.86 Cr |
How is Consolidated Net Profit of GENNEX LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹11 Cr | 83.61 | |
| Mar2024 | ₹6.19 Cr | 50.89 | |
| Mar2023 | ₹4.11 Cr | 1.66 | |
| Mar2022 | ₹4.04 Cr | 117.56 | |
| Mar2021 | ₹1.86 Cr | - | |
Compare Consolidated Net Profit of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹257.8 Cr | -5.6% | 4.4% | -19.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹429,145.0 Cr | -0.1% | -2.5% | 6.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,989.0 Cr | -0.2% | -2.8% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,322.0 Cr | 2.3% | 1.2% | 41.1% | Stock Analytics | |
| CIPLA | ₹112,149.0 Cr | 0.7% | 1.9% | -4.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,483.0 Cr | 0.1% | -2.4% | 2.3% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -5.6% |
4.4% |
-19.7% |
| SENSEX | -1% |
-5.7% |
-9.7% |
You may also like the below Video Courses